Data as of Dec 24
| +0.01 / +0.13%|
The 3 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a -6.17% decrease from the last price of 7.46.
The current consensus among 4 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.